Rose M Cubbon

Author PubWeight™ 9.84^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor.	Bioorg Med Chem Lett	2002	2.21
2	Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulation.	J Biol Chem	2007	1.92
3	Structural and biochemical characterization of the wild type PCSK9-EGF(AB) complex and natural familial hypercholesterolemia mutants.	J Biol Chem	2008	1.41
4	A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptake.	J Biol Chem	2010	1.32
5	A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo.	J Lipid Res	2010	1.29
6	Functional analysis of sites within PCSK9 responsible for hypercholesterolemia.	J Lipid Res	2008	1.03
7	Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).	Bioorg Med Chem Lett	2009	0.86
8	p38 MAP kinase inhibitors: metabolically stabilized piperidine-substituted quinolinones and naphthyridinones.	Bioorg Med Chem Lett	2005	0.75